Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asston PharmaceuticalsBOM:544445 -0.59%19 Days Inventory is 15.12 as of Mar. 2026, which is 46% below its 10-year median of 27.82. GuruFocus rates BOM:544445 with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Asston Pharmaceuticals ranks better than 99.02% on this metric.
The historical rank and industry rank for Asston Pharmaceuticals's Days Inventory or its related term are showing as below:
BOM:544445'
s Days Inventory Range Over the Past 10 Years
Min: 14.74 Med: 27.82 Max: 109.2
Current: 14.74
During the past 5 years, Asston Pharmaceuticals's highest Days Inventory was 109.20. The lowest was 14.74. And the median was 27.82.
BOM:544445's Days Inventory is ranked better than 99.02% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:544445: 14.74
Asston Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (30.87) to Mar. 2026 (15.12).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Asston Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 was 12.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Asston Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.07.
Asston Pharmaceuticals (BOM:544445) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Asston Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Asston Pharmaceuticals's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Asston Pharmaceuticals Days Inventory Related Terms
Asston Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Asston Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Asston Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asston Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Asston Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Asston Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asston Pharmaceuticals (BOM:544445) has a Days Inventory of 15.12 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Asston Pharmaceuticals and its competitors. This is 46% below median its historical median of 27.82. Over the past decade, Asston Pharmaceuticals' Days Inventory has ranged from 14.74 to 109.20. According to the industry distribution chart, Asston Pharmaceuticals ranks #9 out of 923 companies in the Drug Manufacturers industry, placing it in the top 1%.
Is Asston Pharmaceuticals' Days Inventory too high?
Asston Pharmaceuticals' current Days Inventory of 15.12 is 46% below median its 10-year median of 27.82. Over the past 10 years, this metric has ranged from a low of 14.74 to a high of 109.20. The Drug Manufacturers industry median Days Inventory is 164.87. Asston Pharmaceuticals' value of 15.12 is 90.8% below this industry median. Based on the distribution chart, Asston Pharmaceuticals ranks #9 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Asston Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Asston Pharmaceuticals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Asston Pharmaceuticals ranks #9 out of 923 companies for Days Inventory. This places Asston Pharmaceuticals in the top 1% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Asston Pharmaceuticals' value of 15.12 is 90.8% below this benchmark. Historically, Asston Pharmaceuticals' own Days Inventory has ranged from 14.74 to 109.20 over the past decade. While the company's 10-year median is 27.82 vs. the industry median of 164.87, Asston Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asston Pharmaceuticals's current Days Inventory of 15.12 is 90.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Asston Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asston Pharmaceuticals's current Days Inventory is 15.12, which is 46% below median its own 10-year median of 27.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asston Pharmaceuticals stock overvalued right now?
Asston Pharmaceuticals (BOM:544445) has a current Days Inventory of 15.12. The current Days Inventory is 15.12, which is 46% below median its 10-year median of 27.82 and 90.8% below the Drug Manufacturers industry median of 164.87. Asston Pharmaceuticals' overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Asston Pharmaceuticals (BOM:544445), the current Days Inventory is 15.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
19GF Score
Get the complete analysis for BOM:544445
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544445 has been successfully added to your 
